BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1420491)

  • 1. Erythropoietin and peritoneal dialysis: the efficacy of intraperitoneal dosing.
    Nissenson AR
    Perit Dial Int; 1992; 12(4):350-2. PubMed ID: 1420491
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin in patients on peritoneal dialysis.
    Bargman J
    Perit Dial Int; 1989; 9(4):245-6. PubMed ID: 2488375
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacokinetics of intraperitoneal erythropoietin administered undiluted or diluted in dialysate.
    Bargman JM; Jones JE; Petro JM
    Perit Dial Int; 1992; 12(4):369-72. PubMed ID: 1420495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Boelaert JR; Schurgers ML; Matthys EG; Belpaire FM; Daneels RF; De Cre MJ; Bogaert MG
    Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
    Nasu T; Mitui H; Shinohara Y; Hayashida S; Ohtuka H
    Perit Dial Int; 1992; 12(4):373-7. PubMed ID: 1420496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal erythropoietin treatment of children with chronic renal failure.
    Steele BT; Vigneux A
    Pediatr Nephrol; 1995 Jun; 9(3):359-60. PubMed ID: 7632534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Chung WW; Leung CB; Chan K; Lai KN
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation.
    Am J Kidney Dis; 1989 Sep; 14(3):163-9. PubMed ID: 2672796
    [No Abstract]   [Full Text] [Related]  

  • 9. Intraperitoneal administration of recombinant human erythropoietin.
    Frenken LA; Struijk DG; Coppens PJ; Tiggeler RG; Krediet RT; Koene RA
    Perit Dial Int; 1992; 12(4):378-83. PubMed ID: 1420497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of once- versus thrice-weekly subcutaneous recombinant human erythropoietin in children receiving continuous cycling peritoneal dialysis.
    Ongkingco JR; Ruley EJ; Turner ME; Fragale MR
    Am J Nephrol; 1994; 14(1):14-8. PubMed ID: 8017476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin and peritoneal dialysis.
    Digenis GE; Yatzidis H
    Int J Artif Organs; 1990 Jun; 13(6):344-6. PubMed ID: 2199378
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration.
    Eisele G; Bailie GR; Clement C; Wong E
    Perit Dial Int; 1992; 12(1):34-6. PubMed ID: 1543777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of the anaemia of chronic renal failure with erythropoietin: pharmacokinetic studies in patients on haemodialysis and CAPD.
    Hughes RT; Cotes PM; Oliver DO; Pippard MJ; Royston P; Stevens JM; Strong CA; Tam RC; Winearls CG
    Contrib Nephrol; 1989; 76():122-30. PubMed ID: 2582777
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis.
    Reddingius RE; Schröder CH; Koster AM; Monnens LA
    Eur J Pediatr; 1994 Nov; 153(11):850-4. PubMed ID: 7843202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous recombinant human erythropoietin treatment of children undergoing peritoneal dialysis.
    Fine RN
    Contrib Nephrol; 1991; 89():186-9. PubMed ID: 1893725
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythropoietin use in peritoneal dialysis patients.
    Zimmerman SW; Johnson CA
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):38-41. PubMed ID: 1928078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of renal anemia with recombinant human erythropoietin.
    Schaefer RM; Hörl WH; Massry SG
    Am J Nephrol; 1989; 9(5):353-62. PubMed ID: 2679093
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
    Icardi A; Paoletti E; Molinelli G
    Adv Perit Dial; 1990; 6():292-5. PubMed ID: 1982830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Korbet SM
    Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of recombinant human erythropoietin on anemia and dialysis: efficiency in patients undergoing CAPD.
    Schollmeyer P; Lubrich-Birkner I; Steinhauer HB
    Contrib Nephrol; 1990; 87():95-104. PubMed ID: 2093545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.